SEARCH

SEARCH BY CITATION

References

  • 1
    Serious Hazards of Transfusion (SHOT). http://www.shotuk.org (accessed 20 April 2008).
  • 2
    Better Blood Transfusion. Appropriate Use of Blood. London: Department of Health, 2002.
  • 3
    Woolley AL, Hogikyan ND, Gates GA, Haughey BH, Schechtman KB, Goldenberg JL. Effect of blood transfusion on recurrence of head and neck carcinoma. Retrospective review and meta-analysis. Annals of OtoRhinoLaryngology 1992; 101: 72430.
  • 4
    Jones KR, Weissler MC. Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Archives of Otolaryngology – Head and Neck Surgery 1990; 116: 3049.
  • 5
    Kinoshita Y, Udagawa H, Tsutsumi K, et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery 2000; 127: 18592.
  • 6
    Moir MS, Samy RN, Hanasono MM, Terris DJ. Autologous and heterologous blood transfusion in head and neck cancer surgery. Archives of Otolaryngolology- Head and Neck Surgery 1999; 125: 8648.
  • 7
    Neider AM, Carmack AJK, Sved PD, Kim SS, Manoharan M, Soloway MS. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Adult Urology 2005; 65: 304.
  • 8
    Neider AM, Manoharan M, Yang Y, Soloway MS. Intraoperative cell salvage during radical cystectomy does not affect long term survival. Adult Urology 2007; 69: 8814.
  • 9
    Muscari F, Suc B, Vigouroux D, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transplant International 2005; 18: 12369.
  • 10
    Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H. Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Annals of Thoracic and Cardiovascular Surgery 2005; 11: 293300.
  • 11
    James V. A National Blood Conservation Strategy for NBTC and NBS. Report from the Working Party on Autologous Transfusion and the Working Party on Alternatives to Transfusion to the NBS sub-group on the appropriate use of blood. 2004. http://www.dh.gov.uk/en/Publichealth/Healthprotections/Bloodsafety/Bloodsafetygeneralinformation/index/htm (accessed 20 June 2008).
  • 12
    Intraoperative Red Blood Cell Salvage During Radical Prostatectomy or Radical Cystectomy. London: NICE, 2008. http://www.nice.org.uk/guidance/index.jsp?action=download&o=40387.IPG258 (accessed 25 April 2008).
  • 13
    Levine TS, Rolfe KJ, Crow J, et al. The use of cytospin monolayer technique in the cytological diagnosis of vulval and anal disease. Cytopathology 2001; 12: 297305.
  • 14
    Goddard MJ, Wilson B, Grant JW. Comparison of commercially available cytokeratin antibodies in normal and neoplastic adult epithelial and non-epithelial tissues. Journal of Clinical Pathology 1991; 44: 6603.
  • 15
    Moll R. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumours. In: HermannH, HarrisJR, eds. Subcellular Biochemistry Volume 31. New York: Plenum Press, 1998: 20562.
  • 16
    Moll R, Franke WW, Schiller DI. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 1124.
  • 17
    Tseng SCG, Jarvinen MJ, Nelson WG, Huang JW, Woodcock-Mitchell J, Sun TT. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell 1982; 30: 36172.
  • 18
    Woodcock-Mitchell J, Eichner R, Nelson WG, Sun TT. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. Journal of Cell Biology 1982; 95: 5808.
  • 19
    Listrom MB, Dalton MW. Comparison of monoclonal antibodies MAK-6, AE1/AE3 nd CAM-5.2. American Journal of Clinical Pathology 1987; 88: 297301.
  • 20
    Dzik WH, Sherbarne B. Intraoperative blood salvage: medical controversies. Transfusion Medicine Review 1990; 4: 20833.
  • 21
    Waters JH, Biscotti MD, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the caesarean section patient. Anesthesiology 2000; 92: 15316.
  • 22
    Catling SJ, Williams S, Feilding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. International Journal of Obstetric Anesthesia 1999; 8: 7984.
  • 23
    Catling SJ, Freites O, Krishnan S, Gibbs R. Clinical experience with cell salvage in obstetrics – four cases from one UK centre. International Journal of Obstetric Anesthesia 2002; 11: 12834.
  • 24
    Ozmen V, McSwain NE, Nichols RL, Smith J, Flint LM. Autotransfusion of potentially culture-positive blood in abdominal trauma:preliminary data from a prospective study. Journal of Trauma 1992; 32: 369.
  • 25
    Bowley DM, Barker P, Boffard KD. Intraoperative blood salvage in penetrating abdominal trauma: a randomised, controlled trial. World Journal of Surgery 2006; 30: 107480.
  • 26
    Autologous Blood Transfusions. Council on Scientific Affairs, American Medical Association Report. Journal of the American Medical Association 1986; 256: 237880.
  • 27
    Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. International Journal of Cancer 1996; 68: 73943.
  • 28
    Denis MG, Lipart C, Leborgne J, et al. Detection of disseminated tumour cells in peripheral blood of colorectal cancer patients. International Journal of Cancer 1997; 74: 5404.
  • 29
    Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Archives of Surgery 1995; 130: 38793.
  • 30
    Salsbury AJ. The significance of circulating cancer cells. Cancer Treatment Review 1975; 2: 5572.
  • 31
    Fidler IJ. Cancer metastasis. British Medical Bulletin 1991; 47: 15777.
  • 32
    Schoppmeyer K, Frühauf N, Oldhafer K, Seeber S, Kasimir-Bauer S. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases. Oncology Reports 2006; 15: 44954.
  • 33
    Yaw PB, Sentany M, Link WJ, Wahle WM, Glover JL. Tumour cells carried through autotransfusion: contra-indication to intraoperative blood recovery? Journal of the American Medical Association 1975; 231: 4901.
  • 34
    Homan B, Zenner HP, Schauber J, Ackerman R. Tumour cells carried through autotransfusion: are these cells still malignant? Acta Anaesthesiologica Belgica 1984; 35: 519.
  • 35
    Dale RF, Kipling RM, Smith MF, Collier D, Smith PJ. Separation of malignant cells during autotransfusion. British Journal of Surgery 1988; 75: 581.
  • 36
    Karczewski DM, Lema MJ, Glaves D. The efficiency of an autotransfusion system for tumour cell removal from blood salvaged during cancer surgery. Anesthesia and Analgesia 1994; 78: 11315.
  • 37
    Fujimoto J, Okamoto E, Yamanaka N, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Archives of Surgery 1993; 128: 10659.
  • 38
    Miller GV, Ramsden CW, Primrose JN. Autologous transfusion: an alternative to transfusion with banked blood during surgery for cancer. British Journal of Surgery 1991; 78: 7135.
  • 39
    Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB. The potential for re- introduction of tumour cells during intraoperative cell salvage: reduction of risk with use of the RC 400 leucocyte depletion filter. Urology 1996; 47: 17981.
  • 40
    Wiesel M, Gudemann C, Staehler G. Tumour cell separation by cell saver and membrane filter passage. Infusionstherapie 1991; 18: 1434.
  • 41
    Wiesel M, Gudemann C, Staehler G. Separation of urologic tumour cells from cell saver blood using a membrane filter; a new method in autotransfusion? Urologe 1992; 31: 1825.
  • 42
    Torre GC, Ferrari M, Favre A, Razetta F, Borgonov G. A new technique for intraoperative blood recovery in the cancer patient. European Journal of Surgery and Oncology 1994; 20: 56570.
  • 43
    Muller M, Kuhn DF, Hinrichs B, et al. Is the elimination of osteosarcoma cells with intraoperative ‘mesh autotransfusion’ and leucocyte depletion filters possible? Anaesthetist 1996; 45: 8348.
  • 44
    Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filtration removes cancer cells in human blood. Acta Anaesthesioloica Scandinavica 1996; 40: 11820.
  • 45
    Perseghin P, Vigano M, Rocco G, Della Pona C, Buscemi A, Rizzi A. Effectiveness of leucocyte filters in reducing tumour cell contamination after intraoperative cell salvage in lung cancer surgery. Vox Sanguinis 1997; 72: 2214.
  • 46
    Park KL, Kojima O, Tomoyoshi T. Intra-operative autotransfusion in radical cystectomy. British Journal of Urology 1997; 79: 71721.
  • 47
    Update Consensus Conference on Autologous Transfusion. Edinburgh: Royal College of Physicians of Edinburgh, 1998.
  • 48
    Fidler IJ, Talmadge JE. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Research 1986; 46: 516771.
  • 49
    Hansen E. Failed evidence of tumour cell removal from salvaged blood after leucocyte depletion. Transfusion Medicine 2006; 16: 2134.
  • 50
    Hansen E. Cell salvage in the presence of malignancy. Transfusion Alternatives in Transfusion Medicine 2003; 5: 4727.
  • 51
    Klimberg IW, Sirios R, Wajsman Z, Baker J. Intraoperative autotransfusion in urologic oncology. Archives of Surgery 1986; 121: 13269.
  • 52
    Hart OJ, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma bladder. Surgery, Gynecology and Obstetrics 1989; 168: 3026.
  • 53
    Hart OJ, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in patients with invasive bladder cancer: long term follow up. Journal of Urology 1989; 141: 478A.
  • 54
    Pisters LL, Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology 1992; 40: 2115.
  • 55
    Zulim RA, Rocco M, Goodnight J. Intraoperative autotransfusion in hepatic resection for malignancy: is it safe? Archives of Surgery 1993; 128: 20611.
  • 56
    Fujimoto J, Okamoto E, Yamanaka N, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Archives of Surgery 1993; 128: 10659.
  • 57
    Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstetrics and Gynecology 1995; 86: 3738.
  • 58
    Chiusano MA, Finkelstein LH, Mene M, Ginsburgh PC. Use of predeposited autologous blood plus intraoperative autotransfusion compared with use of predeposited autologous blood alone in radical retropubic prostatectomy. Journal of the American Osteopathic Association 1996; 96: 1604.
  • 59
    Davis M, Sofer M, Gomez-Martin O, Bruck D, Soloway MS. The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? British Journal of Urology International 2003; 91: 4746.
  • 60
    Harrison S, Steele RJC. Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. British Journal of Surgery 1992; 79: 3557.
  • 61
    Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma. European Journal of Surgical Oncology 2000; 26: 4927.
  • 62
    Taniguchi Y, Okura M. Prognostic significance of perioperative blood transfusion in oral cavity squamous cell carcinoma. Head and Neck 2003; 25: 9316.
  • 63
    Szakmany T, Dodd M, Dempsey GA, et al. The influence of allogenic blood transfusion in patients having free-flap primary surgery for oral and oropharyngeal squamous cell carcinoma. British Journal of Cancer 2006; 94: 64753.